SCHEMBL6433914

SCHEMBL6433914

Cc1cccc(NC(=O)Nc2ccc(-c3nn(C4CCN(C(=O)CN(C)C(=O)OC(C)(C)C)CC4)c4ncnc(N)c34)cc2F)c1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ LCK P06239 9/20 0.49
▸ SRC P12931 6/20 0.49
▸ KDR P35968 3/20 0.49
▸ TEK Q02763 1/20 0.49
▸ KIT P10721 2/20 0.46
▸ FLT3 P36888 2/20 0.46
▸ AURKA O14965 1/20 0.46
▸ IKBKE Q14164 1/20 0.46
▸ AURKB Q96GD4 1/20 0.46
▸ EGFR P00533 3/20 0.44
▸ BTK Q06187 1/20 0.44
▸ ITK Q08881 1/20 0.43
▸ FYN P06241 2/20 0.43
▸ ABL1 P00519 3/20 0.43
▸ PTK6 Q13882 2/20 0.43
▸ PIK3CD O00329 1/20 0.43
▸ HCK P08631 1/20 0.43
▸ PIK3CA P42336 1/20 0.43
▸ PIK3CB P42338 1/20 0.43
▸ MTOR P42345 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7702572 0.91 LCK (0.52) LCKSRCKDRTEKKIT
SCHEMBL6430834 0.91 LCK (0.53) LCKSRCKDRTEKKIT
SCHEMBL5802530 0.90 LCK (0.54) LCKSRCKDRTEKKIT
SCHEMBL6431538 0.86 LCK (0.53) LCKSRCKDRTEKKIT
SCHEMBL6431567 0.85 LCK (0.57) LCKSRCKDRTEKKIT
SCHEMBL7702573 0.85 LCK (0.52) LCKSRCKDRTEKKIT
SCHEMBL7004695 0.83 LCK (0.50) LCKSRCKDRTEKKIT
Acetic Acid SCHEMBL6434178 0.83 LCK (0.50) LCKSRCKDRTEKKIT
SCHEMBL6434464 0.83 LCK (0.56) LCKSRCKDRTEKKIT
SCHEMBL6430319 0.83 LCK (0.49) LCKSRCKDRTEKKIT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6921763-B2 Pyrazolopyrimidines as therapeutic agents ABBOTT LABORATORIES (US) 2005-07-26 — — US disclosed
US-6660744-B1 Kinase inhibitors ABBOTT GMBH & CO. KG (DE) 2003-12-09 — — US disclosed
EP-1212327-B1 PYRAZOLOPYRIMIDINES AS THERAPEUTIC AGENTS BASF AG (DE) 2003-08-20 — — EP disclosed
Send feedback